ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

Trans-Atlantic Pancreatic Surgery (TAPS) Consortium

doi:10.1245/s10434-023-14752-1

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

Trans-Atlantic Pancreatic Surgery (TAPS) Consortium

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1954-1955
Number of pages	2
Journal	Annals of surgical oncology
Volume	31
Issue number	3
DOIs	https://doi.org/10.1245/s10434-023-14752-1
Publication status	Published - 1 Mar 2024

Access to Document

10.1245/s10434-023-14752-1

Cite this

Trans-Atlantic Pancreatic Surgery (TAPS) Consortium (2024). ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study. Annals of surgical oncology, 31(3), 1954-1955. https://doi.org/10.1245/s10434-023-14752-1

@article{9cd25e0dd6fc4286a32fc4ededfba18c,

title = "ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study",

author = "{Trans-Atlantic Pancreatic Surgery (TAPS) Consortium} and Deesje Doppenberg and Stoop, {Thomas F.} and {van Dieren}, Susan and Katz, {Matthew H.G.} and Janssen, {Quisette P.} and Naaz Nasar and Prakash, {Laura R.} and Theijse, {Rutger T.} and Tzeng, {Ching Wei D.} and Wei, {Alice C.} and Zureikat, {Amer H.} and {Groot Koerkamp}, Bas and Besselink, {Marc G.}",

year = "2024",

month = mar,

day = "1",

doi = "10.1245/s10434-023-14752-1",

language = "English",

volume = "31",

pages = "1954--1955",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "3",

}

Trans-Atlantic Pancreatic Surgery (TAPS) Consortium 2024, 'ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study', Annals of surgical oncology, vol. 31, no. 3, pp. 1954-1955. https://doi.org/10.1245/s10434-023-14752-1

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study. / Trans-Atlantic Pancreatic Surgery (TAPS) Consortium.
In: Annals of surgical oncology, Vol. 31, No. 3, 01.03.2024, p. 1954-1955.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - ASO Visual Abstract

T2 - Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

AU - Trans-Atlantic Pancreatic Surgery (TAPS) Consortium

AU - Doppenberg, Deesje

AU - Stoop, Thomas F.

AU - van Dieren, Susan

AU - Katz, Matthew H.G.

AU - Janssen, Quisette P.

AU - Nasar, Naaz

AU - Prakash, Laura R.

AU - Theijse, Rutger T.

AU - Tzeng, Ching Wei D.

AU - Wei, Alice C.

AU - Zureikat, Amer H.

AU - Groot Koerkamp, Bas

AU - Besselink, Marc G.

PY - 2024/3/1

Y1 - 2024/3/1

UR - http://www.scopus.com/inward/record.url?scp=85184516721&partnerID=8YFLogxK

U2 - 10.1245/s10434-023-14752-1

DO - 10.1245/s10434-023-14752-1

M3 - Article

C2 - 38102327

SN - 1068-9265

VL - 31

SP - 1954

EP - 1955

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 3

ER -

ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study

Access to Document

Other files and links

Cite this